News on Amgen

Amgen starts two critical late-stage trials for weight loss drug MariTide

Wegovy's price cut, Amgen's Ozempic competitor, and Big Pharma's tax cut: Pharma news roundup

Ozempic competitor in the works at Amgen reaches late-stage clinical trials

Amgen just got one step closer to bringing its Ozempic competitor to market

Amgen injects $200m in Hyd with new tech centre

Healthy Returns: Wall Street mulls over Amgen's weight loss drug data

Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau

Stocks making the biggest moves premarket: Amgen, Best Buy, Abercrombie & Fitch, Stellantis and more

Amgen says its Ozempic competitor helped patients lose 20% of their weight. Wall Street isn't impressed

Amgen says no concerns around weight loss drug's bone density data after stock falls

Stocks making the biggest moves midday: Rivian, Cava, Rocket Lab, Amgen and more

Amgen set to open new tech centre in Hyderabad by end of year

Amgen to open new tech and innovation center in Hyderabad by end of 2024

Stocks making the biggest moves premarket: Disney, Airbnb, Rivian, Amgen and more

FDA approves Amgen's treatment for most deadly form of lung cancer

Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance

Amgen teased trial results for its potential Ozempic competitor -- and the stock surged 13%

Amgen Shares Soar on Obesity Drug Progress

Stocks making the biggest moves premarket: Apple, Amgen, Cloudflare and more

Amgen scraps experimental weight loss pill, moves forward with injection

Amgen wants in on the booming weight loss drug market -- and it's taking a different approach

The weight loss drug race has Amgen coming for Novo Nordisk and Eli Lilly

Stocks making the biggest moves premarket: Amgen, Sunnova, Arvinas and more